You may qualify to participate in an international research study to evaluate the safety and tolerability of an investigational drug for patients with type 2 diabetes and kidney disease. Are you at least 18 years old? Do you have type 2 diabetes mellitus and a clinical diagnosis of kidney disease? Eligible study participants will receive study medications, blood pressure checks, physical exams, laboratory tests and ECG at no cost. Participants will  be reimbursed for time and travel. For more information, call the UAB Hypertension Program at 934-9281 or e-mail ccc-hlnresearch@mail.ad.uab.edu.
The UAB Department of Nutrition Sciences is conducting a research study to evaluate the effectiveness of an investigational drug to treat Type 2 DM. To qualify, you must be 18 years old or older, diagnosed with type 2 diabetes, kidney disease and have risk factors for a cardiovascular event (such as heart attack and stroke). Qualified participants will receive study drug, diet/exercise counseling, EKG, physical and diabetic supplies. There is no charge for participation. Compensation for time and travel may also be available. For more information, and to see if you might be eligible to join, please contact (205)975-8217 or (205)996-4020.
We are looking for healthy men and women ages 18-65 to participate in a research study. You must have no history of gastrointestinal or kidney disease. We are conducting a study to examine the presence of Oxalobacter, a naturally occurring molecule in our bodies. This study involves collection of stool specimens. Compensation is provided. Please send an email to kidneystone@uabmc.edu if you are interested.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.